Hello,

We noticed you're browsing in private or incognito mode.

To continue reading this article, please exit incognito mode or log in.

Not an Insider? Subscribe now for unlimited access to online articles.

David Rotman

A View from David Rotman

More than a Hundred Genetic Variants Tied to Schizophrenia

A multinational research collaboration has identified more than 100 genetic loci associated with an increased risk for the psychiatric disease.

  • July 22, 2014

To a large extent, schizophrenia and other psychiatric disorders are illnesses caused by genes. Now teams of scientists from research centers around the world, looking at the genetics of nearly 80,000 people, have worked together to identify 108 genetic loci associated with the disorder. It is the largest genetic study ever conducted of a psychiatric disorder.

Researchers are finally beginning to gain some scientific understanding of many common brain disorders, including schizophrenia (see “Shining a Light on Madness”). The lack of such understanding to date has meant there hasn’t been a true new breakthrough drug to treat these disorders in 50 years. And while we’re still far from turning new insights into effective and safe drugs, at least the emerging knowledge is giving researchers some options in exploring potential treatments.

In today’s study, published in Nature, the scientists pointed out that, importantly, the more than 100 variants were not randomly distributed but tend to affect genes expressed in certain tissues and cell types. That’s good news because it suggests that despite the genetic complexity, drug researchers might be able to zero in on specific common pathways or types of cells in attempts to tackle these disorders.

In announcing the results, leading scientists at the Broad Institute, one of the groups in the collaboration, touted the results as a turning point in how we view brain disorders. “Five years ago, we didn’t know a single gene related to these [psychiatric] diseases, not a [single] pathway,” said Eric Lander, Broad’s director. It was a perspective echoed by Steven Hyman, director of Broad’s Stanley Center for Psychiatric Research: “We’ve turned with this Nature paper [and related research] what had been a scientifically forbidding and featureless landscape into a landscape with toeholds and opportunities and glimmers of hope.”

Be the leader your company needs. Implement ethical AI.
Join us at EmTech Digital 2019.

Register now
More from Rewriting Life

Reprogramming our bodies to make us healthier.

Want more award-winning journalism? Subscribe to Insider Plus.
  • Insider Plus {! insider.prices.plus !}*

    {! insider.display.menuOptionsLabel !}

    Everything included in Insider Basic, plus the digital magazine, extensive archive, ad-free web experience, and discounts to partner offerings and MIT Technology Review events.

    See details+

    Print + Digital Magazine (6 bi-monthly issues)

    Unlimited online access including all articles, multimedia, and more

    The Download newsletter with top tech stories delivered daily to your inbox

    Technology Review PDF magazine archive, including articles, images, and covers dating back to 1899

    10% Discount to MIT Technology Review events and MIT Press

    Ad-free website experience

/3
You've read of three free articles this month. for unlimited online access. You've read of three free articles this month. for unlimited online access. This is your last free article this month. for unlimited online access. You've read all your free articles this month. for unlimited online access. You've read of three free articles this month. for more, or for unlimited online access. for two more free articles, or for unlimited online access.